Seasonality of Clostridium difficile infections in Southern Germany

M Reil; M P M Hensgens; E J Kuijper; T Jakobiak; H Gruber; M Kist; S Borgmann

doi:10.1017/S0950268811002627

Seasonality of Clostridium difficile infections in Southern Germany

M Reil
, M P M Hensgens
, E J Kuijper
, T Jakobiak
, H Gruber
, M Kist
, S Borgmann^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Between 2000 and 2009, the total number of patients with Clostridium difficile infections increased considerably in Southeastern Germany. A clear seasonality was observed with a higher number of affected patients occurring in the winter months (January-March). Moxifloxacin and erythromycin-resistant C. difficile PCR ribotypes 001 (72%) and 027 (4·6%) were the most commonly isolated strains.

Original language	English
Pages (from-to)	1787-93
Number of pages	7
Journal	Epidemiology and Infection
Volume	140
Issue number	10
DOIs	https://doi.org/10.1017/S0950268811002627
Publication status	Published - Oct 2012
Externally published	Yes

Keywords

Anti-Bacterial Agents/pharmacology
Aza Compounds/pharmacology
Clostridioides difficile/isolation & purification
Clostridium Infections/epidemiology
Cluster Analysis
Drug Resistance, Bacterial
Erythromycin/pharmacology
Fluoroquinolones
Genotype
Germany/epidemiology
Humans
Moxifloxacin
Quinolines/pharmacology
Ribotyping
Seasons

Access to Document

10.1017/S0950268811002627

Cite this

@article{d3adda6bfeb8477589851086b44e839b,

title = "Seasonality of Clostridium difficile infections in Southern Germany",

abstract = "Between 2000 and 2009, the total number of patients with Clostridium difficile infections increased considerably in Southeastern Germany. A clear seasonality was observed with a higher number of affected patients occurring in the winter months (January-March). Moxifloxacin and erythromycin-resistant C. difficile PCR ribotypes 001 (72\%) and 027 (4·6\%) were the most commonly isolated strains.",

keywords = "Anti-Bacterial Agents/pharmacology, Aza Compounds/pharmacology, Clostridioides difficile/isolation \& purification, Clostridium Infections/epidemiology, Cluster Analysis, Drug Resistance, Bacterial, Erythromycin/pharmacology, Fluoroquinolones, Genotype, Germany/epidemiology, Humans, Moxifloxacin, Quinolines/pharmacology, Ribotyping, Seasons",

author = "M Reil and Hensgens, \{M P M\} and Kuijper, \{E J\} and T Jakobiak and H Gruber and M Kist and S Borgmann",

year = "2012",

month = oct,

doi = "10.1017/S0950268811002627",

language = "English",

volume = "140",

pages = "1787--93",

journal = "Epidemiology and Infection",

issn = "0950-2688",

publisher = "Cambridge University Press",

number = "10",

}

TY - JOUR

T1 - Seasonality of Clostridium difficile infections in Southern Germany

AU - Reil, M

AU - Hensgens, M P M

AU - Kuijper, E J

AU - Jakobiak, T

AU - Gruber, H

AU - Kist, M

AU - Borgmann, S

PY - 2012/10

Y1 - 2012/10

N2 - Between 2000 and 2009, the total number of patients with Clostridium difficile infections increased considerably in Southeastern Germany. A clear seasonality was observed with a higher number of affected patients occurring in the winter months (January-March). Moxifloxacin and erythromycin-resistant C. difficile PCR ribotypes 001 (72%) and 027 (4·6%) were the most commonly isolated strains.

AB - Between 2000 and 2009, the total number of patients with Clostridium difficile infections increased considerably in Southeastern Germany. A clear seasonality was observed with a higher number of affected patients occurring in the winter months (January-March). Moxifloxacin and erythromycin-resistant C. difficile PCR ribotypes 001 (72%) and 027 (4·6%) were the most commonly isolated strains.

KW - Anti-Bacterial Agents/pharmacology

KW - Aza Compounds/pharmacology

KW - Clostridioides difficile/isolation & purification

KW - Clostridium Infections/epidemiology

KW - Cluster Analysis

KW - Drug Resistance, Bacterial

KW - Erythromycin/pharmacology

KW - Fluoroquinolones

KW - Genotype

KW - Germany/epidemiology

KW - Humans

KW - Moxifloxacin

KW - Quinolines/pharmacology

KW - Ribotyping

KW - Seasons

U2 - 10.1017/S0950268811002627

DO - 10.1017/S0950268811002627

M3 - Article

C2 - 22152928

SN - 0950-2688

VL - 140

SP - 1787

EP - 1793

JO - Epidemiology and Infection

JF - Epidemiology and Infection

IS - 10

ER -

Seasonality of Clostridium difficile infections in Southern Germany

Abstract

Keywords

Access to Document

Fingerprint

Cite this